Courtesy of Tris Pharma Medical Affairs.

This site is intended for U.S. healthcare professionals only.

Within this guide, the current epidemiology of ADHD in children, adolescents, and adults is provided, along with a basic outline of ADHD pathophysiology and theories of ADHD causation.

This guide outlines important ADHD measurement tools and scales that are commonly used in the biomedical literature to report clinical trial efficacy and safety data. Methods of reporting and interpreting pharmacokinetic data are also included. Finally, to provide an aid in understanding the body of evidence related to ADHD research, a review of various techniques commonly used in the reporting of inferential and descriptive statistics associated with ADHD clinical trials is provided.